Status:
COMPLETED
The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load
Lead Sponsor:
King Abdulaziz University
Conditions:
SARS-CoV-2
COVID-19
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Preoperative antiseptic mouth rinses have been widely used as a standard protocol before routine dental treatment reduces oral microorganism counts. During dental procedures, aerosolized microorganism...
Detailed Description
Saliva specimens will be collected from COVID-19-positive patients presenting to TETAMMAN clinics from January to March 2021. The total number of participants in this study will be 90 participants, wi...
Eligibility Criteria
Inclusion
- Adults age 18 years or older presented to TETAMMAN clinics, Jeddah, Saudi Arabia.
- COVID-19-positive patients confirmed by RT-PCR and within two days of oral or nasopharyngeal swabs
- Asymptomatic or within seven days of the onset of symptoms.
- Has the ability to rinse and expectorate.
Exclusion
- Participants who established antiviral, corticosteroid, antimicrobial, or immunosuppressive medications.
- Known allergy to one of the constituents of the mouth rinse
- Thyroid disease or on current radioactive iodine treatment
- Pregnant or breastfeeding women
- Lithium therapy
- History of radiotherapy or chemotherapy
- Use of mouthwash before presented to TETAMMAN clinics
Key Trial Info
Start Date :
January 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04721457
Start Date
January 3 2021
End Date
December 10 2021
Last Update
July 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alhamra TETAMMAN clinic (PHC)
Jeddah, Saudi Arabia